Major enterprise platform companies are racing to build tools for a new class of users: artificial intelligence agents. One example of this was apparent today with ...

Databricks said annualized revenue has jumped more than 80% from a year earlier and now sits at $6.9 billion, up from a figure of $5.4 billion in the fiscal fourth quarter. While Databricks is ...

SAN FRANCISCO, June 16 (Reuters) - Databricks said on Tuesday it had agreed to buy startup Panther Labs, as the U.S. data analytics provider pushes deeper into the cybersecurity business.

Get traffic data and keyword intel on competitors instantly. Databricks put an end to weeks of rumors today as it announced CustomerLake, an agentic CDP. The announcement came at the company’s Data + ...

Databricks is in talks to raise at $165-175bn, four months after closing at $134bn. CEO Ghodsi has privately signalled an IPO as soon as next year. Discussions are early-stage and the round has not ...

Arsalan Tavakoli was at his bachelor party in 2013 when Ali Ghodsi, a computer science researcher at the University of California, Berkeley, pulled him aside. The two had become colleagues and friends ...

Investment deepens alignment between Databricks and v4c as the company joins an exclusive portfolio of ecosystem leaders following breakout momentum v4c.ai, a strategic boutique pure-play Databricks ...

Before “Seinfeld” and “Curb Your Enthusiasm,” there was “Prognosis: Negative,” a film script written by Larry David in the 1980s that was never produced. Thanks to a Reddit user from Rochester, N.Y., ...

Director Destin Daniel Cretton, stars Tom Holland and Zendaya, and crew members offer an annotated script from the Sony/Marvel release.

When Lyria 3 launched last month, Gemini could generate 30-second audio clips from prompts. With the new advanced model, the chatbot can now create tracks up to 3 minutes long and follow instructions ...

With an overflowing war chest from its $5 billion raise that closed last month (not to mention billions in revenue), Databricks is acquiring. The company, best known for its cloud data analytics ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...